CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-08 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −1,467 | $13.34 | $20K | 23,787 |
| 2026-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +1,650 | 23,442 | ||
| 2026-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +5,225 | 28,667 | ||
| 2026-02-12 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −3,413 | $14.25 | $49K | 25,254 |
| 2025-12-05 | Rottinghaus Scott T. Chief Medical Officer | Sale | −798 | $14.23 | $11K | 21,792 |
| 2025-11-25 | Rottinghaus Scott T. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2025-08-08 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −2,217 | $6.99 | $15K | 22,590 |
| 2025-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +9,750 | 27,668 | ||
| 2025-02-12 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −2,861 | $5.59 | $16K | 24,807 |
| 2024-12-06 | Rottinghaus Scott T. Chief Medical Officer | Sale 10b5-1 | −866 | $8.06 | $7K | 17,918 |
| 2024-11-27 | Rottinghaus Scott T. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +87,000 | 87,000 | ||
| 2024-08-08 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −1,466 | $12.73 | $19K | 18,784 |
| 2024-07-15 | Rottinghaus Scott T. Chief Medical Officer | Option exercise 10b5-1 | +5,375 | $8.99 | $48K | 27,092 |
| 2024-07-15 | Rottinghaus Scott T. Chief Medical Officer | Sale 10b5-1 | −5,375 | $17.08 | $92K | 21,717 |
| 2024-07-15 | Rottinghaus Scott T. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,375 | 80,625 | ||
| 2024-07-12 | Rottinghaus Scott T. Chief Medical Officer | Sale 10b5-1 | −2,271 | $15.04 | $34K | 21,717 |
| 2024-07-11 | Rottinghaus Scott T. Chief Medical Officer | Sale 10b5-1 | −4,299 | $15.07 | $65K | 23,988 |
| 2024-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +2,576 | 29,042 | ||
| 2024-02-12 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −755 | $12.41 | $9K | 28,287 |
| 2023-12-05 | Rottinghaus Scott T. Sr. VP & CMO | Sale | −534 | $9.63 | $5K | 26,466 |
Page 1 of 2 · 26 trades